SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001354488-14-001360
Filing Date
2014-03-24
Accepted
2014-03-24 16:00:41
Documents
11

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT oxbt_424b.htm 424B3 1320446
2 LICENSE AGREEMENT oxbt_103.htm EX-10.3 1453173
3 AMENDMENT TO COMMON STOCK PURCHASE WARRANT oxbt_104.htm EX-10.4 19616
4 CERTIFICATION oxbt_ex311.htm EX-31.1 13471
5 CERTIFICATION oxbt_ex312.htm EX-31.2 13497
6 CERTIFICATION oxbt_ex321.htm EX-32.1 7172
7 CERTIFICATION oxbt_ex322.htm EX-32.2 7462
8 GRAPHIC img001.jpg GRAPHIC 17051
9 GRAPHIC img002.jpg GRAPHIC 9678
10 GRAPHIC img003.jpg GRAPHIC 14588
11 GRAPHIC image01.jpg GRAPHIC 4434
  Complete submission text file 0001354488-14-001360.txt   2899735
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
OXYGEN BIOTHERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 424B3 | Act: 33 | File No.: 333-187466 | Film No.: 14713252
SIC: 8731 Services-Commercial Physical & Biological Research